| Product NDC: | 76325-100 |
| Proprietary Name: | Ravicti |
| Non Proprietary Name: | glycerol phenylbutyrate |
| Active Ingredient(s): | 1.1 g/mL & nbsp; glycerol phenylbutyrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 76325-100 |
| Labeler Name: | Hyperion Therapeutics, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203284 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130228 |
| Package NDC: | 76325-100-04 |
| Package Description: | 4 BOTTLE in 1 CARTON (76325-100-04) > 25 mL in 1 BOTTLE |
| NDC Code | 76325-100-04 |
| Proprietary Name | Ravicti |
| Package Description | 4 BOTTLE in 1 CARTON (76325-100-04) > 25 mL in 1 BOTTLE |
| Product NDC | 76325-100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glycerol phenylbutyrate |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20130228 |
| Marketing Category Name | NDA |
| Labeler Name | Hyperion Therapeutics, Inc. |
| Substance Name | GLYCEROL PHENYLBUTYRATE |
| Strength Number | 1.1 |
| Strength Unit | g/mL |
| Pharmaceutical Classes |